1.Chinese surgical robot-assisted surgery for parotid tumor:a case report
Guiquan ZHU ; Zhongkai MA ; Chang CAO ; Jialu HE ; Jiawei HONG ; Ruiting REN ; Hui XIA ; Bing YAN ; Xiaoyi WANG ; Long-Jiang LI ; Chunjie LI
West China Journal of Stomatology 2024;42(2):262-267
Robotic surgery is known as the"third technological revolution"in the field of surgery,and is an important milestone in the development of modern surgery.However,our country's innovative surgical robot industry is still in its early stages,and it is only being utilized in certain surgical fields.To explore the effectiveness of the application of do-mestic surgical robot in oral and maxillofacial surgery,the author successfully completed a case of benign parotid tumor resection with the assistance of a domestic autonomous robot.The operation was successful,facial nerve function was preserved,and postoperative wound healing was good.
2.Integrating transcriptomics, metabolomics, and network pharmacology to investigate multi-target effects of sporoderm-broken spores of Ganoderma lucidum on improving HFD-induced diabetic nephropathy rats.
Lidan HU ; Lili YU ; Zhongkai CAO ; Yue WANG ; Caifeng ZHU ; Yayu LI ; Jiazhen YIN ; Zhichao MA ; Xuelin HE ; Ying ZHANG ; Wunan HUANG ; Yuelin GUAN ; Yue CHEN ; Xue LI ; Xiangjun CHEN
Journal of Pharmaceutical Analysis 2024;14(12):101105-101105
Diabetes mellitus (DM) is a major metabolic disease endangering global health, with diabetic nephropathy (DN) as a primary complication lacking curative therapy. Sporoderm-broken spores of Ganoderma lucidum (GLP), an herbal medicine, has been used for the treatment of metabolic disorders. In this study, DN was induced in Sprague-Dawley rats using streptozotocin (STZ) and a high-fat diet (HFD), and the protective mechanisms of GLP were investigated through transcriptomic, metabolomic, and network pharmacology (NP) analyses. Our results demonstrated that GLP intervention ameliorated renal damage and inflammation levels in DN rats. Integrative metabolomic and transcriptomic analysis revealed that GLP treatment modulated glucose and cellular energy metabolisms by regulating relevant genes. GLP significantly suppressed the inflammations by impacting glucose and energy metabolism-related gene expression (Igfbp1 and Angptl4) and enhanced metabolic biomarkers of 4-Aminocatechol. In addition, NP analysis further indicated that GLP may efficiently alleviate DN via immune-related pathways. In conclusion, this study provides supportive evidence of the anti-inflammatory effects of GLP supplements, highlighting their potential for promising clinical applications in treating DN.
3.Isorhapontigenin protects against doxorubicin-induced cardiotoxicity
Panxia WANG ; Minghui WANG ; Yuehuai HU ; Jianxing CHEN ; Yanjun CAO ; Cui LIU ; Zhongkai WU ; Juan SHEN ; Jing LU ; Peiqing LIU
Acta Pharmaceutica Sinica B 2021;11(3):680-693
As an effective anticancer drug, the clinical limitation of doxorubicin (Dox) is the time- and dose-dependent cardiotoxicity. Yes-associated protein 1 (YAP1) interacts with transcription factor TEA domain 1 (TEAD1) and plays an important role in cell proliferation and survival. However, the role of YAP1 in Dox-induced cardiomyopathy has not been reported. In this study, the expression of YAP1 was reduced in clinical human failing hearts with dilated cardiomyopathy and Dox-induced
4.Experimental study on application recombinant human bone morphogenetic protein 2(rhBMP-2)/poly-lactide-co-glycolic acid (PLGA)/fibrin sealant(FS) on repair of rabbit radial bone defect.
Zhongkai FAN ; Yang CAO ; Zhe ZHANG ; Mingchao ZHANG ; Wei LU ; Lei TANG ; Qi YAO ; Gang LU
Journal of Biomedical Engineering 2012;29(5):903-907
This paper is aimed to investigate the repair of rabbit radial bone defect by the recombinant human bone morphogenetic protein 2/poly-lactideco-glycolic acid microsphere with fibrin sealant (rhBMP-2/PLGA/FS). The radial bone defect models were prepared using New Zealand white rabbits, which were randomly divided into 3 groups, experiment group which were injected with eMP-2/PLGA/FS at bone defect location, control group which were injected with FS at bone defect location, and blank control group without treatment. The ability of repairing bone defect was evaluated with X-ray radiograph. Bone mineral density in the defect regions was analysed using the level of ossification. The osteogenetic ability of repairing bone defect, the degradation of the material, the morphologic change and the bone formation were assessed by HE staining and Masson staining. The result showed that rhBMP-2/PLGA/FS had overwhelming superiority in the osteogenetic ability and quality of bone defect over the control group, and it could promote the repair of bone defect and could especially repair the radial bone defect of rabbit well. It may be a promising and efficient synthetic bone graft.
Animals
;
Bone Morphogenetic Protein 2
;
therapeutic use
;
Bone Regeneration
;
drug effects
;
Bone Substitutes
;
therapeutic use
;
Female
;
Fibrin Tissue Adhesive
;
therapeutic use
;
Lactic Acid
;
therapeutic use
;
Male
;
Microspheres
;
Polyglycolic Acid
;
therapeutic use
;
Rabbits
;
Radius Fractures
;
therapy
;
Recombinant Proteins
;
therapeutic use
;
Transforming Growth Factor beta
;
therapeutic use

Result Analysis
Print
Save
E-mail